BackZyVersa Therapeutics Overview

ZyVersa Therapeutics Current Cash

Latest current cash for ZVSA: $300M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$302.66M
↓ 81.22% YoYΔ $-1.31B vs prior year quarter

Peer average

Loading

ZyVersa Therapeutics Current Cash History

Loading

ZyVersa Therapeutics vs. peers: Current Cash Comparison

Loading

ZyVersa Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ZyVersa Therapeutics (ZVSA) FAQ

ZyVersa Therapeutics (ZVSA) currently reports a current cash of $300M as of March 2026. That compares with $1.6B in the prior-year period — down 81.2% year over year. Use the charts on this page to explore ZyVersa Therapeutics's current cash history and peer comparisons.

ZyVersa Therapeutics's current cash decreased from $1.6B to $300M — a 81.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ZyVersa Therapeutics reported $300M in current cash as of March 2026. That compares with $1.6B in the prior-year period — down 81.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $300M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ZyVersa Therapeutics, and consider following ZVSA for alerts when major investors trade the stock.